Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China

References

• Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8:e191–e203. doi:10.1016/S2214-109X(19)30482-6.
   PubMed Web of Science ®Google Scholar
• Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88:63–73. doi:10.1038/sj.bjc.6600688.
   PubMed Web of Science ®Google Scholar
• Ma L, Cong X, Shi M, Wang XH, Liu HY, Bian ML. Distribution of human papillomavirus genotypes in cervical lesions. Exp Ther Med. 2017;13:535–41. doi:10.3892/etm.2016.4000.
   PubMed Web of Science ®Google Scholar
• Soto D, Song C, McLaughlin-Drubin ME. Epigenetic alterations in human papillomavirus-associated cancers. Viruses. 2017;9. doi:10.3390/v9090248.
   PubMed Web of Science ®Google Scholar
• Patel C, Brotherton JM, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, Marshall H. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill. 2018;23. doi:10.2807/1560-7917.ES.2018.23.41.1700737.
   PubMedGoogle Scholar
• Kavanagh K, Pollock KG, Cuschieri K, Palmer T, Cameron RL, Watt C, Bhatia R, Moore C, Cubie H, Cruickshank M, Robertson C.Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis. 2017;17:1293–302. doi:10.1016/S1473-3099(17)30468-1.
   PubMed Web of Science ®Google Scholar
• Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, et al. Looking beyond human papillomavirus (HPV) genotype 16 and 18: defining HPV genotype distribution in cervical cancers in Australia prior to vaccination. Int J Cancer. 2017;141(8):1576–84. doi:10.1002/ijc.30871.
   PubMed Web of Science ®Google Scholar
• Siu JY-M, Fung TKF, Leung LH-M. Social and cultural construction processes involved in HPV vaccine hesitancy among Chinese women: a qualitative study. Int J Equity Health. 2019;18. doi:10.1186/s12939-019-1052-9.
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–99. doi:10.1086/657321.
   PubMed Web of Science ®Google Scholar
• Yin Y. HPV vaccination in China needs to be more cost-effective. The Lancet. 2017;390:1735–36. doi:10.1016/S0140-6736(17)32606-5.
   PubMed Web of Science ®Google Scholar
• Ortiz RR, Smith A, Coyne-Beasley T. A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination. Hum Vaccin Immunother. 2019;15:1465–75. doi:10.1080/21645515.2019.1581543.
   PubMed Web of Science ®Google Scholar
• Liu SS, Chan KY, Leung RC, Chan KK, Tam KF, Luk MH, Lo SST, Fong DYT, Cheung ANY, Lin ZQ, et al. Prevalence and risk factors of human papillomavirus (HPV) infection in southern Chinese women - a population-based study. PLoS One. 2011;6:e19244. doi:10.1371/journal.pone.0019244.
   PubMed Web of Science ®Google Scholar
• Lin M, Yang LY, Li LJ, Wu JR, Peng YP, Luo ZY. Genital human papillomavirus screening by gene chip in Chinese women of Guangdong province. Aust N Z J Obstet Gynaecol. 2008;48:189–94. doi:10.1111/j.1479-828X.2008.00844.x.
   PubMed Web of Science ®Google Scholar
• Wang X, Ji Y, Li J, Dong H, Zhu B, Zhou Y, Wang J, Zhou X, Wang Y, Peppelenbosch MP, et al. Prevalence of human papillomavirus infection in women in the autonomous region of Inner Mongolia: A population-based study of a Chinese ethnic minority. J Med Virol. 2018;90:148–56. doi:10.1002/jmv.24888.
   PubMed Web of Science ®Google Scholar
• Jing L, Zhong X, Zhong Z, Huang W, Liu Y, Yang G, Zhang X, Zou J, Jing C, Wei X, et al. Prevalence of human papillomavirus infection in Guangdong Province, China: a population-based survey of 78,355 women. Sex Transm Dis. 2014;41:732–38. doi:10.1097/OLQ.0000000000000201.
   PubMed Web of Science ®Google Scholar
• Li C, Wu M, Wang J, Zhang S, Zhu L, Pan J, Zhang W. A population-based study on the risks of cervical lesion and human papillomavirus infection among women in Beijing, People’s Republic of China. Cancer Epidemiol Biomarkers Prev. 2010;19:2655–64. doi:10.1158/1055-9965.EPI-10-0212.
   PubMed Web of Science ®Google Scholar
• Xue H, Lin X, Li T, Yan X, Guo K, Zhang Y. Prevalence and genotype distribution of human papillomavirus infection in asymptomatic women in Liaoning province, China. J Med Virol. 2015;87:1248–53. doi:10.1002/jmv.24029.
   PubMed Web of Science ®Google Scholar
• Li J, Wang YY, Tian XF, Nan X, Yan T, Wang P, Fu YL, Wang GQ. HPV genotype analysis for women in Shaanxi Province of China. Genet Mol Res. 2016;15. doi:10.4238/gmr15047178.
   Google Scholar
• Du R, Chen ZF, Li XH, Ding Y, Zhang Y. Human papillomavirus infection among Uyghur women with cervical intraepithelial neoplasia in Xinjiang area. Eur J Gynaecol Oncol. 2015;36:564–68.
   PubMed Web of Science ®Google Scholar
• Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Pearse A, Montoya GD, Robertson M, Shearman CA, Castle PE. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer. 2013;132:198–207. doi:10.1002/ijc.27608.
   PubMed Web of Science ®Google Scholar
• Murillo R, Herrero R, Sierra MS, Forman D. Cervical cancer in central and South America: burden of disease and status of disease control. Cancer Epidemiol. 2016;44(Suppl 1):S121–S30. doi:10.1016/j.canep.2016.07.015.
   PubMedGoogle Scholar
• Quek SC, Lim BK, Domingo E, Soon R, Park J-S, Vu TN, Tay EH, Le QT, Kim Y-T, Vu BQ. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia. Int J Gynecological Cancer. 2013;23:148–56. doi:10.1097/IGC.0b013e31827670fd.
   PubMed Web of Science ®Google Scholar
• Duan R, Qiao Y, Clifford G, Zhao F. Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China. Cancer Med. 2019;9:374–84. doi:10.1002/cam4.2697.
   PubMed Web of Science ®Google Scholar
• Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128:927–35. doi:10.1002/ijc.25396.
   PubMed Web of Science ®Google Scholar
• Chen Q, Luo ZY, Lin M, Lin QL, Chen CY, Yang C, Xie L-X, Li H, Zheng J-K, Yang L-Y, et al. Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province. Asian Pac J Cancer Prev. 2012;13:1519–24. doi:10.7314/APJCP.2012.13.4.1519.
   PubMedGoogle Scholar
• Long W, Yang Z, Li X, Chen M, Liu J, Zhang Y, Sun X. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix. Virol J. 2018;15:e94. doi:10.1186/s12985-018-1003-x.
   PubMed Web of Science ®Google Scholar
• Wolday D, Derese M, Gebressellassie S, Tsegaye B, Ergete W, Gebrehiwot Y, Caplan O, Wolf DG, Maayan S. HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia. Infect Agent Cancer. 2018;13(1):28. doi:10.1186/s13027-018-0201-x.
   PubMedGoogle Scholar
• World Health Organization. Electronic address swi. Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations. Vaccine. 2017;35:5753–55. doi:10.1016/j.vaccine.2017.05.069.
   PubMed Web of Science ®Google Scholar
• Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FAR, Moriarty AT, Waxman AG, Wilbur DC. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147–72. doi:10.3322/caac.21139.
   PubMed Web of Science ®Google Scholar
• Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh P, Ferreccio C, Hieu NT, Matos E, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991–98. doi:10.1016/S0140-6736(05)67069-9.
   PubMed Web of Science ®Google Scholar
• Zhang L, Bi Q, Deng H, Xu J, Chen J, Zhang M, Mu X. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution. BMC Infect Dis. 2017;17(1):107. doi:10.1186/s12879-017-2223-1.
   PubMed Web of Science ®Google Scholar
• Bulk S, Berkhof J, Bulkmans NW, Zielinski GD, Rozendaal L, van Kemenade FJ, Snijders PJF, Meijer CJLM. Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer. 2006;94(1):171–75. doi:10.1038/sj.bjc.6602915.
   PubMed Web of Science ®Google Scholar
• Yan Y, Yan M, Luan RS, Zhang XX, Xu SK. Study on the sexual behavior and its influencing factors among college students in Shenzhen, Guangdong. Chin J Sch Health. 2016;37:1784–86.
   Google Scholar
• Wagner M, Bennetts L, Patel H, Welner S, de Sanjose S, Weiss TW. Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in females. Infect Agent Cancer. 2015;10:13. doi:10.1186/s13027-015-0008-y.
   PubMed Web of Science ®Google Scholar
• Wang S, Wei H, Wang N, Zhang S, Zhang Y, Ruan Q, Jiang W, Xiao Q, Luan X, Qian X. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC Cancer. 2012;12(1):160. doi:10.1186/1471-2407-12-160.
   PubMedGoogle Scholar
• Song B, Ding C, Chen W, Sun H, Zhang M, Chen W. Incidence and mortality of cervical cancer in China, 2013. Chinese J Cancer Res. 2017;29:471–76. doi:10.21147/j..1000-9604.2017.06.01.
   PubMed Web of Science ®Google Scholar
• Santhanes D, Yong CP, Yap YY, Saw PS, Chaiyakunapruk N, Khan TM. Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: A systematic review and meta-analysis. Sci Rep. 2018;8:3640. doi:10.1038/s41598-018-21912-x.
   PubMed Web of Science ®Google Scholar
• Zhang SK, Pan XF, Wang SM, Yang CX, Gao XH, Wang ZZ, Li M, Ren Z-F, Zheng -Q-Q, Ma W, et al. Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: a nationwide survey in China. Ann Epidemiol. 2015;25:231–35. doi:10.1016/j.annepidem.2014.12.009.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang J, Fang Y, Gross DL, Wong MCS, Wong ELY, Lau JTF. Parental acceptability of HPV vaccination for boys and girls aged 9-13years in China - A population-based study. Vaccine. 2018;36:2657–65. doi:10.1016/j.vaccine.2018.03.057.
   PubMed Web of Science ®Google Scholar
• Lin W, Wang Y, Liu Z, Chen B, Yuan S, Wu B, Gong L. Inequalities in awareness and attitude towards HPV and its vaccine between local and migrant residents who participated in cervical cancer screening in Shenzhen, China. Cancer Res Treat. 2020;52:207–17. doi:10.4143/crt.2019.053.
   PubMed Web of Science ®Google Scholar
• Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care (Engl). 2017;26. doi:10.1111/ecc.12444.
   PubMed Web of Science ®Google Scholar
• Wang X, Tian X, Liu F, Zhao Y, Sun M, Chen D, Lu C, Wang Z, Shi X, Zhang Q. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer. 2010;10(1):19. doi:10.1186/1471-2407-10-19.
   PubMedGoogle Scholar
• Trottier H, Ferreira S, Thomann P, Costa MC, Sobrinho JS, Prado JC, Rohan TE, Villa LL, Franco EL. et al. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res. 2010;70:8569–77. doi:10.1158/0008-5472.CAN-10-0621.
   PubMed Web of Science ®Google Scholar
• Barchitta M, Maugeri A, Quattrocchi A, Agrifoglio O, Scalisi A, Agodi A. The association of dietary patterns with high-risk human papillomavirus infection and cervical Cancer: A cross-sectional study in Italy. Nutrients. 2018;10. doi:10.3390/nu10040469.
   Web of Science ®Google Scholar